Sale of 47 Ishinkan facilities in western Japan to NSSK for receipt of 17.4 billion yen. Strengthening of the financial base after the transfer will expand capacity to invest in growth areas. Maintain Ishinkan as a stable earnings base and shift the comprehensive medical support business into a growth driver. Upon approval at an extraordinary shareholders meeting, transfer gains are expected in the fiscal year ending September 2027.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7071","jir_company_name":"Amvis Holdings, Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-28","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/7071-20260928-04.pdf","jir_short_summary":"Sale of 47 Ishinkan facilities in western Japan to NSSK for receipt of 17.4 billion yen. Strengthening of the financial base after the transfer will expand capacity to invest in growth areas. Maintain Ishinkan as a stable earnings base and shift the comprehensive medical support business into a growth driver. Upon approval at an extraordinary shareholders meeting, transfer gains are expected in the fiscal year ending September 2027.","jir_summary":"### Overview and Strategy of the Proposal\nBy transferring 47 Ishinkan facilities primarily in western Japan, the company will strengthen its financial base and position the comprehensive medical support business as a new growth driver. The transfer proceeds and reduction in interest-bearing debt will improve net debt, allowing concentration of resources in the Tokyo metropolitan area and eastern Japan while maintaining the Ishinkan business as a stable revenue base.\n\n### Future Growth and Organizational Structure\nSecure investment capacity to expand the comprehensive medical support business and cultivate AIZIA (a new business) as the core for DX\/AI introduction and expanded deployment. Establish a structure to delegate authority for Ishinkan to the next generation, accelerating allocation of management resources and business expansion.","jir_financial_highlights":"Transfer target: 47 Ishinkan facilities mainly in western Japan (Unknown)\nTransfer price: 17.4 hundred million yen (Unknown)\nScheduled transfer date: November 16 (TBD)\nImpact on future growth: Transfer gain expected in FY2027\/9 (Forecast)\nDrivers of net debt improvement: 88 hundred million yen reduction in borrowings, 1 hundred million yen reduction in lease liabilities, assumed 17.0 hundred million yen increase in cash (Estimated basis)","jir_category":"","jir_hashtags":"#ShareBuyback, #ExecutivePersonnel","jir_key_figures":"Transfer target: 47 Ishinkan facilities mainly in western Japan\nTransfer price: 17.4 hundred million yen\nTransfer date: November 16\nExpected increase in cash: 17.0 hundred million yen","jir_meta_title":"Amvis Holdings, Inc. \u2014 Strengthening Financial Base via Ishinkan Transfer; Growth Strategy Toward Comprehensive Medical Support\uff5cSeptember 2026","jir_meta_description":"Amvis Holdings, Inc. will transfer 47 Ishinkan facilities in western Japan to NSSK. With expected transfer gains and increased cash, the company will strengthen its financial base and position the comprehensive medical support business as a new growth driver. Overview of development plans and organizational restructuring.","jir_og_title":"Amvis Holdings, Inc. \u2014 Strengthening Financial Base via Ishinkan Transfer; Growth Strategy Toward Comprehensive Medical Support","jir_og_description":"Transfer of 47 Ishinkan facilities in western Japan with receipt of 17.4 billion yen. Strengthening the financial base expands capacity for growth investment. The comprehensive medical support business will be a new growth driver, and deployment in DX\/AI will be accelerated.","jir_og_image_url":"","jir_chart_data_collection":"[]","ir_related_company":17546,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"tender_offer","footnotes":""},"sector":[],"importance":[],"class_list":["post-123869","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n